Satsuma Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q2 2020 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Satsuma Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q2 2020 to Q1 2023.
  • Satsuma Pharmaceuticals, Inc. Debt-to-equity for the quarter ending March 31, 2023 was 12.7 %, a 86.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 12.7 +5.89 +86.5% Mar 31, 2023
Q4 2022 10.7 +4.8 +81% Dec 31, 2022
Q3 2022 9.06 +2.62 +40.7% Sep 30, 2022
Q2 2022 7.91 +0.35 +4.63% Jun 30, 2022
Q1 2022 6.81 -1.7 -20% Mar 31, 2022
Q4 2021 5.92 -4.49 -43.1% Dec 31, 2021
Q3 2021 6.44 -3.29 -33.8% Sep 30, 2021
Q2 2021 7.56 -1.43 -15.9% Jun 30, 2021
Q1 2021 8.51 Mar 31, 2021
Q4 2020 10.4 Dec 31, 2020
Q3 2020 9.74 Sep 30, 2020
Q2 2020 8.99 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.